BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 3 filers reported holding BIOSCRIP INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,086,000 | +43.6% | 2,340,700 | +10.5% | 0.06% | +52.8% |
| Q1 2019 | $4,237,000 | -46.7% | 2,118,500 | -4.9% | 0.04% | -49.3% |
| Q4 2018 | $7,956,000 | +16.5% | 2,228,500 | +1.1% | 0.07% | +51.1% |
| Q3 2018 | $6,832,000 | +9.6% | 2,204,000 | +3.6% | 0.05% | +9.3% |
| Q2 2018 | $6,232,000 | +27.0% | 2,127,000 | +6.6% | 0.04% | +26.5% |
| Q1 2018 | $4,908,000 | -7.6% | 1,995,000 | +9.3% | 0.03% | -2.9% |
| Q4 2017 | $5,309,000 | +1003.7% | 1,824,500 | +942.6% | 0.04% | +1066.7% |
| Q3 2017 | $481,000 | +628.8% | 175,000 | +4275.0% | 0.00% | – |
| Q2 2013 | $66,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coliseum Capital Management, LLC | 5,622,410 | $5,847,000 | 2.64% |
| NORTH TIDE CAPITAL, LLC | 8,500,000 | $8,840,000 | 1.51% |
| WYNNEFIELD CAPITAL INC | 3,700,000 | $3,848,000 | 1.39% |
| Alta Fundamental Advisers LLC | 2,330,774 | $2,424,000 | 1.20% |
| ARDSLEY ADVISORY PARTNERS LP | 6,350,000 | $6,604,000 | 1.09% |
| Camber Capital Management LP | 10,180,000 | $10,587,000 | 0.55% |
| PERKINS CAPITAL MANAGEMENT INC | 298,000 | $310,000 | 0.34% |
| Hawk Ridge Capital Management | 340,429 | $354,000 | 0.18% |
| Eidelman Virant Capital | 220,000 | $228,000 | 0.13% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 227,280 | $236,000 | 0.11% |